![New scheme to routinely test patients for inherited cancer genes | Leaders in Pharmaceutical Business Intelligence (LPBI) Group New scheme to routinely test patients for inherited cancer genes | Leaders in Pharmaceutical Business Intelligence (LPBI) Group](https://pharmaceuticalintelligence.com/wp-content/uploads/2021/06/article-7.3.7.-new-scheme-to-routinely-test-patients-for-inherited-cancer-genes-1.png)
New scheme to routinely test patients for inherited cancer genes | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
![Frontiers | The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016–2021 Frontiers | The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016–2021](https://www.frontiersin.org/files/Articles/1020543/fgene-13-1020543-HTML/image_m/fgene-13-1020543-t003.jpg)
Frontiers | The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016–2021
![Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes | Hereditary Cancer in Clinical Practice | Full Text Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes | Hereditary Cancer in Clinical Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13053-018-0102-4/MediaObjects/13053_2018_102_Fig1_HTML.png)
Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes | Hereditary Cancer in Clinical Practice | Full Text
![Cancers | Free Full-Text | NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases Cancers | Free Full-Text | NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases](https://pub.mdpi-res.com/cancers/cancers-12-03140/article_deploy/html/images/cancers-12-03140-ag-550.jpg?1604307020)
Cancers | Free Full-Text | NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases
![Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes - ScienceDirect Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525157817302593-figs4.jpg)
Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes - ScienceDirect
![Cancers | Free Full-Text | Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing Cancers | Free Full-Text | Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing](https://pub.mdpi-res.com/cancers/cancers-14-01434/article_deploy/html/images/cancers-14-01434-sch001.png?1646972610)
Cancers | Free Full-Text | Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing
![PDF) Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer PDF) Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer](https://i1.rgstatic.net/publication/312081774_Benchmarking_of_Whole_Exome_Sequencing_and_Ad_Hoc_Designed_Panels_for_Genetic_Testing_of_Hereditary_Cancer/links/587208c708ae6eb871c433a1/largepreview.png)